Industry Experts

Victor’s career spans over 30 years in research focused on targeted cancer therapeutics, antibody technologies, and the biology of apoptosis. As Head of Cell Biology at ImmunoGen, Inc., he played a pivotal role in the discovery of three FDA-approved anti-cancer biologics—Elahere, Sarclisa, and Kadcyla—as well as the identification of two key cell death suppressors encoded by cytomegalovirus. He later joined Forbius, Inc. as Director of Discovery, where his work on a clinical-stage TGF-beta trap contributed to the company's acquisition by BMS. Victor is now the co-founder and Chief Scientific Officer of ImmuVia, Inc., a biotech company developing novel ADC-mimetics.